RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication
Artículo científico (JournalArticle)
Electromechanical computational modeling of heart failure provides extensive analysis of cardiac pathophysiological features
[EN] This study applies a high-performance, fully coupled 3D-0D electromechanical model to simulate cardiac function across multiple scenarios of heart failure with reduced ejection fraction (HFrEF), including ventricular tachycardia post-myocardial infarction and acute hypertension. By integrating biomechanical deformation, electromechanical coupling, and hemodynamic feedback, the model provides a comprehensive analysis of different stages of heart failure. A physiologically detailed 3D-0D electromechanical model was used to simulate pressure-volume loops under different pathological conditions. The model incorporates hemodynamic coupling within an electromechanical framework to quantify left ventricular performance markers in virtual scenarios. Additionally, myocardial strains along the principal fiber direction were computed to assess systolic dysfunction and deformation. The simulations accurately predicted the hemodynamic impact of HFrEF according to their electrophysiological and mechanical properties. The computationally derived pressure-volume loops demonstrated a strong agreement with clinical findings, highlighting key features of HFrEF such as reduced stroke volume, impaired contractility, and decreased ejection fraction. Furthermore, scar-related conduction abnormalities were associated with an increased risk of ventricular tachycardia, with failing hearts exhibiting greater hemodynamic instability during arrhythmic episodes. The proposed computational framework provides a powerful tool for investigating HFrEF progression and electromechanical dysfunction. By accurately replicating pressure-volume loop characteristics and hemodynamic alterations commonly seen in clinical settings, this model enhances the understanding of HFrEF and may support the development of targeted therapeutic strategies., This work was partially funded by grant PID2022-136273OA-C33 and by grant PID2022-140553OB-C41 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU. EC, AZ, P.G-M MV, and JAS acknowledge the European Union - EIC Project No 190134524: "ELEM Virtual Heart Populations for Supercomputers" (ELVIS). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or EISMEA. Neither the European Union nor the granting authority can be held responsible for them. AZ, MV, and JAS acknowledge the European Union's Horizon Europe research and innovation program under grant agreement No 101136728 (VITAL). Views and opinions expressed are, however, those of the authors only and do not necessarily reflect those of the European Union or EISMEA. Neither the European Union nor the granting authority can be held responsible for them. JMP has received funding from the European Union's Horizon 2020 research and innovation program under Marie Sk & lstrok;odowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and the Government of Catalonia's Agency for Business Competitiveness (ACCIo)
Project:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-104356RB-C41
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-136273OA-C33
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-140553OB-C41
,
European Commission / H2020 801342
,
European Commission / HE 101136728
,
European Commission / HE 190134524